Mapping Diabetes in Quebec: Validating Medico-administrative Algorithms for Type 1 Diabetes, Type 2 Diabetes and LADA

Launched by UNIVERSITE DU QUEBEC EN OUTAOUAIS · Aug 23, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "Mapping Diabetes in Quebec," aims to improve how we identify different types of diabetes, specifically Type 1, Type 2, and Latent Autoimmune Diabetes in Adults (LADA). The study will look at the medical records of people diagnosed with diabetes in Quebec, including children and young adults up to 40 years old, to see if certain methods can accurately classify their diabetes type. Researchers want to answer important questions like how common each type of diabetes is and whether these methods work well across different age groups.

To participate in this study, individuals must have been diagnosed with one of these types of diabetes between 1997 and 2024 and live in Quebec. The trial is currently not recruiting participants, but when it does, those who qualify will have their medical data analyzed, including information about their medications and doctor visits, to validate the accuracy of the classification methods. This research is important because it could help healthcare providers better understand and treat diabetes in the population.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Individuals diagnosed with Type 1, Type 2, or Latent Autoimmune Diabetes in Adults (LADA) based on clinical or self-reported data.
• • Participants diagnosed between 1997 and 2024.
• • Residents of Quebec with available medico-administrative records from 1997 to 2024.
• Exclusion Criteria:
• • Non-residents of Quebec during the study period.